Alibaba Q4 Earnings Preview

Chinese e-commerce giant Alibaba (BABA) reports its Q4 earnings tomorrow morning before the bell, and no matter how you look at it, the fourth quarter was a big one for the company.

In the last three months of the year, Alibaba raised $13B in a secondary listing in Hong Kong, closed at a fresh record high above $210, and set a new record with $38.4B in sales on Singles Day alone. For Americans tracking at home, that’s more than US consumers spent online on Thanksgiving Day, Black Friday, Cyber Monday, and Amazon Prime Day…combined!

In other words, the company’s outlook was looking bright in Q4, and the market has set correspondingly high expectations heading into tomorrow’s earnings release. According to FactSet, analysts are expecting BABA to report $2.27 in EPS (up from $1.82 in Q4 last year) on $22.7B in revenue (up from $17.5B last year). 54 of the 56 analysts tracked by FactSet have “buy” ratings on the stock, with the other two analysts maintaining “hold” ratings, and an overall price target of $242 over the next 12 months.

While the outlook through Q4 was undoubtedly bright, the biggest question on traders’ minds will be around how the outbreak of coronavirus has impacted consumer demand in China. This information will not be in the backward-looking reported figures, but management’s guidance for the year will give insight into the expected scale of the disruption to consumer demand, manufacturing production, and labor delivery. In other words, the company’s outlook moving forward will be the biggest driver for the stock.

Technically speaking, BABA remains in a clear uptrend, recovering relatively quickly from the nearly 15% late-January swoon to trade back above $220. A strong report, with solid guidance for the year ahead, would likely take the stock to fresh record highs above $231; this would mirror the recent earnings-driven breakouts in massive US technology names like Amazon and Microsoft. On the other hand, a disappointing earnings report and acknowledgement that coronavirus is likely to lead to major disruptions throughout the year could take the stock back down toward the psychologically-significant $200 level, which has served as both resistance and support in recent months.

Source: TradingView, GAIN Capital

From time to time, StoneX Financial Pty Ltd (“we”, “our”) website may contain links to other sites and/or resources provided by third parties. These links and/or resources are provided for your information only and we have no control over the contents of those materials, and in no way endorse their content. Any analysis, opinion, commentary or research-based material on our website is for information and educational purposes only and is not, in any circumstances, intended to be an offer, recommendation or solicitation to buy or sell. You should always seek independent advice as to your suitability to speculate in any related markets and your ability to assume the associated risks, if you are at all unsure. No representation or warranty is made, express or implied, that the materials on our website are complete or accurate. We are not under any obligation to update any such material.

As such, we (and/or our associated companies) will not be responsible or liable for any loss or damage incurred by you or any third party arising out of, or in connection with, any use of the information on our website (other than with regards to any duty or liability that we are unable to limit or exclude by law or under the applicable regulatory system) and any such liability is hereby expressly disclaimed.

FOREX.com is a trading name of StoneX Financial Pty Ltd.

The material provided herein is general in nature and does not take into account your objectives, financial situation or needs.

While every care has been taken in preparing this material, we do not provide any representation or warranty (express or implied) with respect to its completeness or accuracy. This is not an invitation or an offer to invest nor is it a recommendation to buy or sell investments.

StoneX recommends you to seek independent financial and legal advice before making any financial investment decision. Trading CFDs and FX on margin carries a higher level of risk, and may not be suitable for all investors. The possibility exists that you could lose more than your initial investment and CFD investors do not own or have any rights to the underlying assets.

It is important you consider our Financial Services Guide and Product Disclosure Statement (PDS) available at www.forex.com/en-au/terms-and-policies/, before deciding to acquire or hold our products. As a part of our market risk management, we may take the opposite side of your trade. Our Target Market Determination (TMD) is also available at www.forex.com/en-au/terms-and-policies/.

StoneX Financial Pty Ltd, Suite 42.01, 264 George Street, Sydney, NSW 2000 (ACN 141 774 727, AFSL 345646) is the CFD issuer and our products are traded off exchange.

Delayed London Stock Exchange (LSE) Data

The London Stock Exchange (LSE) market data displayed or referenced on this website is provided on a delayed basis and is not in real time. The delay period may vary but is typically at least 15 minutes. This data is intended for information purposes only and should not be relied upon for trading, investment, or other financial decisions. We do not guarantee the completeness, reliability, or suitability of the data for any particular purpose. Users should consult real-time data sources and obtain professional advice before making any financial decisions.